Drug Approval Package
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Drug Approval Package

  • Print
  • Share
  • E-mail

Reminyl (Galantamine Hydrobromide) Oral Solution
Company:  Janssen Research Foundation
Application No.:  21-224
Approval Date: 6/22/2001


Date created: November 20, 2001

Back to Top    Drugs@FDA


Note: Documents in PDF format require the Adobe Acrobat Reader®.